These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 2120551

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children.
    Usonis V, Bakasenas V, Chitour K, Clemens R.
    Infection; 1998; 26(4):222-6. PubMed ID: 9717679
    [Abstract] [Full Text] [Related]

  • 43. Interferon-gamma production closely related to antibody production in lymphocyte cultures stimulated with mumps virus.
    Nakayama T, Unno S, Urano T, Osano M, Sasaki K, Makino S.
    Kitasato Arch Exp Med; 1990 Sep; 63(2-3):99-106. PubMed ID: 2128947
    [Abstract] [Full Text] [Related]

  • 44. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children.
    Hiltunen M, Hyöty H, Leinikki P, Akerblom HK, Tuomilehto J, Vesikari T.
    Diabet Med; 1994 Dec; 11(10):942-6. PubMed ID: 7895458
    [Abstract] [Full Text] [Related]

  • 45. [Conjugated vaccine against measles, rubella and mumps].
    Vopr Virusol; 1989 Dec; 34(1):117-9. PubMed ID: 2728403
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
    Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ, Starr SE.
    J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Immunization of healthy children with mumps-rubella bivalent live vaccine and simultaneous vaccination with mumps-rubella and varicella vaccines].
    Takayama N, Kidokoro M, Suzuki K, Morita M.
    Kansenshogaku Zasshi; 1991 Oct; 65(10):1271-5. PubMed ID: 1791323
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G, Peña B, Marimón JM, Pérez-Trallero E.
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [Abstract] [Full Text] [Related]

  • 57. Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR.
    Mitchell LA, Tingle AJ, Décarie D, Lajeunesse C.
    Can J Public Health; 1998 Apr; 89(5):325-8. PubMed ID: 9813922
    [Abstract] [Full Text] [Related]

  • 58. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland.
    Davidkin I, Peltola H, Leinikki P, Valle M.
    Vaccine; 2000 Jul 15; 18(27):3106-12. PubMed ID: 10856790
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B, Böttiger M.
    Vaccine; 1994 Feb 15; 12(2):129-33. PubMed ID: 8147093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.